⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15402932 | 1.00 | — | — | |
| SCHEMBL13953149 | 1.00 | — | — | |
| SCHEMBL635281 | 1.00 | — | — | |
| SCHEMBL8247090 | 1.00 | — | — | |
| SCHEMBL13059823 | 1.00 | — | — | |
| SCHEMBL562255 | 1.00 | — | — | |
| SCHEMBL1160926 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL1645935 | 0.98 | GRM2 (0.41) | — | |
| Hydrochloric Acid SCHEMBL2897513 | 0.98 | GRM2 (0.41) | — | |
| Cadaverine Tartrate SCHEMBL15402726 | 0.89 | TSHR (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 215 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118290798-B | Ageing-resistant PET film and preparation method thereof | 扬州博恒新能源材料科技有限公司 | 2024-10-25 | — | — | CN | claimed |
| CN-118290798-A | Ageing-resistant PET film and preparation method thereof | 扬州博恒新能源材料科技有限公司 | 2024-07-05 | — | — | CN | claimed |
| CN-118021525-A | Medical cotton swab and preparation method thereof | 河南飘安集团有限公司 | 2024-05-14 | — | — | CN | claimed |
| CN-112592477-B | Modified organic silicon polymer, preparation method thereof and lithium secondary battery | 深圳市优宝新材料科技有限公司 | 2023-03-03 | — | — | CN | claimed |
| CN-113308052-B | Sprayable modified polypropylene material and preparation method and application thereof | 万华化学（宁波）有限公司 | 2022-07-12 | — | — | CN | claimed |
| CN-113308052-A | Sprayable modified polypropylene material and preparation method and application thereof | 万华化学（宁波）有限公司 | 2021-08-27 | — | — | CN | claimed |
| CN-112592477-A | Modified organic silicon polymer, preparation method thereof and lithium secondary battery | 深圳市优宝新材料科技有限公司 | 2021-04-02 | — | — | CN | claimed |
| EP-3124469-A1 | PROCESS FOR PRODUCING 1-ARYLIMINO-2-VINYLCYCLOPROPANECARBOXYLIC ACID DERIVATIVE | Kaneka Corporation (JP) | 2017-02-01 | — | — | EP | claimed |
| US-20140142337-A1 | 1-AMINO-2-VINYLCYCLOPROPANE CARBOXYLIC ACID AMIDE AND SALT THEREOF, AND METHOD FOR PRODUCING SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2014-05-22 | — | — | US | claimed |
| EP-2725012-A1 | 1-AMINO-2-VINYL CYCLOPROPANE CARBOXYLIC ACID AMIDE, SALT OF SAME, AND METHOD FOR PRODUCING SAME | Mitsubishi Gas Chemical Company, Inc. (JP) | 2014-04-30 | — | — | EP | claimed |
| EP-2465845-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE 1-AMINO-2-VINYLCYCLOPROPANECARBOXYLIC ACID ESTER | Sumitomo Chemical Company, Limited (JP) | 2012-06-20 | — | — | EP | claimed |
| US-20120135441-A1 | ENZYMES AND METHODS FOR RESOLVING AMINO VINYL CYCLOPROPANE CARBOXYLIC ACID DERIVATIVES | DR. REDDY'S LABORATORIES, INC. (US) | 2012-05-31 | — | — | US | claimed |
| EP-2448912-A2 | ENZYMES AND METHODS FOR RESOLVING AMINO VINYL CYCLOPROPANE CARBOXYLIC ACID DERIVATIVES | Dr. Reddy's Laboratories, Ltd. (IN) | 2012-05-09 | — | — | EP | claimed |
| WO-2011003063-A2 | ENZYMES AND METHODS FOR RESOLVING AMINO VINYL CYCLOPROPANE CARBOXYLIC ACID DERIVATIVES | DR. REDDY'S LABORATORIES LTD. (IN) | 2011-01-06 | — | — | WO | claimed |
| CN-101143892-B | Method for resolving enantiomer by enzyme catalysis | BOEHRINGER INGELHEIM CA LTD | 2010-12-08 | — | — | CN | claimed |
| US-20090292129-A1 | PROCESS FOR RESOLVING RACEMIC MIXTURES AND A DIASTEREOISOMERIC COMPLEX OF A RESOLVING AGENT AND AN ENANTIOMER OF INTEREST | ABIOGEN PHARMA S.P.A. (IT) | 2009-11-26 | — | — | US | claimed |
| CN-101379029-A | A process for resolving racemic mixtures and a diastereoisomeric complex of a resolving agent and an enantiomer of interest | ABIOGEN PHARMA SPA (IT) | 2009-03-04 | — | — | CN | claimed |
| EP-1986996-A2 | A PROCESS FOR RESOLVING RACEMIC MIXTURES AND A DIASTEREOISOMERIC COMPLEX OF A RESOLVING AGENT AND AN ENANTIOMER OF INTEREST | Abiogen Pharma S.p.A. (IT) | 2008-11-05 | — | — | EP | claimed |
| WO-2007088571-A2 | A PROCESS FOR RESOLVING RACEMIC MIXTURES AND A DIASTEREOISOMERIC COMPLEX OF A RESOLVING AGENT AND AN ENANTIOMER OF INTEREST | ABIOGEN PHARMA S.P.A. (IT) | 2007-08-09 | — | — | WO | claimed |
| CN-119264505-A | High-resilience soft foaming polyethylene material and preparation method thereof | 杭州锦煌科技有限公司 | 2025-01-07 | — | — | CN | disclosed |
| CN-118290798-B | Ageing-resistant PET film and preparation method thereof | 扬州博恒新能源材料科技有限公司 | 2024-10-25 | — | — | CN | disclosed |
| CN-118290798-A | Ageing-resistant PET film and preparation method thereof | 扬州博恒新能源材料科技有限公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-118021525-A | Medical cotton swab and preparation method thereof | 河南飘安集团有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-118021525-A | Medical cotton swab and preparation method thereof | 河南飘安集团有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-112592477-B | Modified organic silicon polymer, preparation method thereof and lithium secondary battery | 深圳市优宝新材料科技有限公司 | 2023-03-03 | — | — | CN | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| CN-113308052-B | Sprayable modified polypropylene material and preparation method and application thereof | 万华化学（宁波）有限公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-113308052-A | Sprayable modified polypropylene material and preparation method and application thereof | 万华化学（宁波）有限公司 | 2021-08-27 | — | — | CN | disclosed |
| CN-112592477-A | Modified organic silicon polymer, preparation method thereof and lithium secondary battery | 深圳市优宝新材料科技有限公司 | 2021-04-02 | — | — | CN | disclosed |
| EP-2586769-B1 | METHOD FOR PRODUCING (1R, 2S)-1-AMINO-2-VINYL CYCLOPROPANE CARBOXYLIC ACID ESTER THAT HAS IMPROVED OPTICAL PURITY | KANEKA CORP (JP) | 2019-01-16 | — | — | EP | disclosed |
| CN-105384660-B | A kind of preparation method of a-amino acid | 广东东阳光药业有限公司 | 2018-10-16 | — | — | CN | disclosed |
| CN-105037347-B | The polymorph of the huge ring inhibitor of HCV | 泰博特克药品有限公司 | 2018-06-01 | — | — | CN | disclosed |
| CN-106164044-B | Process for producing 1-arylimino-2-vinylcyclopropanecarboxylic acid derivative | 株式会社钟化 | 2018-05-04 | — | — | CN | disclosed |
| CN-104230918-B | The polymorph of the huge ring inhibitor of HCV | 爱尔兰詹森科学公司 | 2018-01-26 | — | — | CN | disclosed |
| CN-102627639-B | Macrocydic inhibitors of hepatitis c virus. | 爱尔兰詹森科学公司 | 2017-04-12 | — | — | CN | disclosed |
| EP-3124469-A1 | PROCESS FOR PRODUCING 1-ARYLIMINO-2-VINYLCYCLOPROPANECARBOXYLIC ACID DERIVATIVE | Kaneka Corporation (JP) | 2017-02-01 | — | — | EP | disclosed |
| CN-106164044-A | Process for producing 1-arylimino-2-vinylcyclopropanecarboxylic acid derivative | 株式会社钟化 | 2016-11-23 | — | — | CN | disclosed |
| CN-103030636-B | The macrocyclic hcv inhibitors of hepatitis C virus | Ireland Jansen scientific company (IE) | 2016-03-02 | — | — | CN | disclosed |
| CN-105254637-A | PYRIMIDINE SUBSTITUTED MACROCYCLIC INHIBITORS | JANSSEN R & D IRELAND | 2016-01-20 | — | — | CN | disclosed |
| EP-2300491-B1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2016-01-06 | — | — | EP | disclosed |
| CN-101627020-B | HCV inhibiting macrocyclic phenylcarbamates | TIBOTEC PHARM LTD | 2015-06-17 | — | — | CN | disclosed |
| CN-102388023-B | Organic compounds and their uses | NOVARTIS AG | 2014-05-28 | — | — | CN | disclosed |
| US-20140142337-A1 | 1-AMINO-2-VINYLCYCLOPROPANE CARBOXYLIC ACID AMIDE AND SALT THEREOF, AND METHOD FOR PRODUCING SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2014-05-22 | — | — | US | disclosed |
| US-20140142337-A1 | 1-AMINO-2-VINYLCYCLOPROPANE CARBOXYLIC ACID AMIDE AND SALT THEREOF, AND METHOD FOR PRODUCING SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2014-05-22 | — | — | US | disclosed |
| US-20140142337-A1 | 1-AMINO-2-VINYLCYCLOPROPANE CARBOXYLIC ACID AMIDE AND SALT THEREOF, AND METHOD FOR PRODUCING SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2014-05-22 | — | — | US | disclosed |
| US-20140142337-A1 | 1-AMINO-2-VINYLCYCLOPROPANE CARBOXYLIC ACID AMIDE AND SALT THEREOF, AND METHOD FOR PRODUCING SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2014-05-22 | — | — | US | disclosed |
| EP-2725012-A1 | 1-AMINO-2-VINYL CYCLOPROPANE CARBOXYLIC ACID AMIDE, SALT OF SAME, AND METHOD FOR PRODUCING SAME | Mitsubishi Gas Chemical Company, Inc. (JP) | 2014-04-30 | — | — | EP | disclosed |
| EP-2725012-A1 | 1-AMINO-2-VINYL CYCLOPROPANE CARBOXYLIC ACID AMIDE, SALT OF SAME, AND METHOD FOR PRODUCING SAME | Mitsubishi Gas Chemical Company, Inc. (JP) | 2014-04-30 | — | — | EP | disclosed |
| EP-2725012-A1 | 1-AMINO-2-VINYL CYCLOPROPANE CARBOXYLIC ACID AMIDE, SALT OF SAME, AND METHOD FOR PRODUCING SAME | Mitsubishi Gas Chemical Company, Inc. (JP) | 2014-04-30 | — | — | EP | disclosed |
| EP-2684864-A1 | METHOD OF PRODUCING OPTICALLY ACTIVE 1-AMINO-2-VINYLCYCLOPROPANE CARBOXYLIC ACID ESTER | Sumitomo Chemical Company Limited (JP) | 2014-01-15 | — | — | EP | disclosed |
| CN-103203010-A | Pharmaceutical Compositions Comprising Hepatitis C Inhibitor Compounds | BOEHRINGER INGELHEIM INT | 2013-07-17 | — | — | CN | disclosed |
| CN-103204903-A | Hepatitis c inhibitor compounds | BOEHRINGER INGELHEIM INT | 2013-07-17 | — | — | CN | disclosed |
| EP-2586769-A1 | METHOD FOR PRODUCING (1R, 2S)-1-AMINO-2-VINYL CYCLOPROPANE CARBOXYLIC ACID ESTER THAT HAS IMPROVED OPTICAL PURITY | KANEKA CORPORATION (JP) | 2013-05-01 | — | — | EP | disclosed |
| EP-2364321-B1 | HCV inhibitors | BRISTOL MYERS SQUIBB CO (US) | 2013-04-17 | — | — | EP | disclosed |
| WO-2013052362-A1 | HEPATITIS C VIRUS INHIBITORS | ENANTA PHARMACEUTICALS, INC. (US) | 2013-04-11 | — | — | WO | disclosed |
| EP-2028186-B1 | Hepatitis C inhibitor tri-peptides | BOEHRINGER INGELHEIM CA LTD (CA) | 2013-01-23 | — | — | EP | disclosed |
| WO-2012176715-A1 | 1-AMINO-2-VINYL CYCLOPROPANE CARBOXYLIC ACID AMIDE, SALT OF SAME, AND METHOD FOR PRODUCING SAME | 三菱瓦斯化学株式会社 (JP) | 2012-12-27 | — | — | WO | disclosed |
| US-8299021-B2 | Macrocyclic inhibitors of hepatitis C virus replication | INTERMUNE, INC. (US) | 2012-10-30 | — | — | US | disclosed |
| WO-2012109398-A1 | MACROCYCLIC SERINE PROTEASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE FOR TREATING HCV INFECTIONS | IDENIX PHARMACEUTICALS, INC. (US) | 2012-08-16 | — | — | WO | disclosed |
| US-20120208995-A1 | NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION | ARRAY BIOPHARMA, INC. (US) | 2012-08-16 | — | — | US | disclosed |
| EP-2465845-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE 1-AMINO-2-VINYLCYCLOPROPANECARBOXYLIC ACID ESTER | Sumitomo Chemical Company, Limited (JP) | 2012-06-20 | — | — | EP | disclosed |
| EP-2459582-A1 | HEPATITIS C VIRUS NS3 PROTEASE INHIBITORS | Merck Sharp & Dohme Corp. (US) | 2012-06-06 | — | — | EP | disclosed |
| US-20120135441-A1 | ENZYMES AND METHODS FOR RESOLVING AMINO VINYL CYCLOPROPANE CARBOXYLIC ACID DERIVATIVES | DR. REDDY'S LABORATORIES, INC. (US) | 2012-05-31 | — | — | US | disclosed |
| CN-102471239-A | Process for producing optically active 1-amino-2-vinylcyclopropanecarboxylic acid ester | SUMITOMO CHEMICAL CO | 2012-05-23 | — | — | CN | disclosed |
| EP-2448912-A2 | ENZYMES AND METHODS FOR RESOLVING AMINO VINYL CYCLOPROPANE CARBOXYLIC ACID DERIVATIVES | Dr. Reddy's Laboratories, Ltd. (IN) | 2012-05-09 | — | — | EP | disclosed |
| EP-2417134-A1 | MACROCYCLIC SERINE PROTEASE INHIBITORS | IDENIX Pharmaceuticals, Inc. (US) | 2012-02-15 | — | — | EP | disclosed |
| US-8044023-B2 | Hepatitis C virus inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-10-25 | — | — | US | disclosed |
| US-20110245529-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE VINYLCYCLOPROPANECARBOXYLIC ACID DERIVATIVE AND OPTICALLY ACTIVE VINYLCYCLOPROPANEAMINO ACID DERIVATIVE | KANEKA CORPORATION (JP) | 2011-10-06 | — | — | US | disclosed |
| US-20110245529-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE VINYLCYCLOPROPANECARBOXYLIC ACID DERIVATIVE AND OPTICALLY ACTIVE VINYLCYCLOPROPANEAMINO ACID DERIVATIVE | KANEKA CORPORATION (JP) | 2011-10-06 | — | — | US | disclosed |
| EP-2364321-A1 | HEPATITIS C VIRUS INHIBITORS | Bristol-Myers Squibb Company (US) | 2011-09-14 | — | — | EP | disclosed |
| CN-102112486-A | Hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2011-06-29 | — | — | CN | disclosed |
| US-7968748-B2 | Process for resolving racemic mixtures and a diastereoisomeric complex of a resolving agent and an enantiomer of interest | ABIOGEN PHARMA S.P.A. (IT) | 2011-06-28 | — | — | US | disclosed |
| EP-1771454-B1 | HEPATITIS C INHIBITOR PEPTIDE ANALOGS | BOEHRINGER INGELHEIM INT (DE) | 2011-06-15 | — | — | EP | disclosed |
| CN-102083821-A | Hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2011-06-01 | — | — | CN | disclosed |
| EP-2305695-A2 | Macrocyclic inhibitors of Hepatitis C virus replication | Intermune, Inc. (US) | 2011-04-06 | — | — | EP | disclosed |
| EP-2305697-A2 | Macrocyclic inhibitors of Hepatitis C virus replication | Intermune, Inc. (US) | 2011-04-06 | — | — | EP | disclosed |
| EP-2305696-A2 | Macrocyclic inhibitors of Hepatitis C virus replication | Intermune, Inc. (US) | 2011-04-06 | — | — | EP | disclosed |
| EP-2305698-A2 | Macrocyclic inhibitors of Hepatitis C virus replication | Intermune, Inc. (US) | 2011-04-06 | — | — | EP | disclosed |
| EP-2300491-A1 | HEPATITIS C VIRUS INHIBITORS | Bristol-Myers Squibb Company (US) | 2011-03-30 | — | — | EP | disclosed |
| CN-101228180-B | Tripeptides as hepatitis C virus inhibitors | BRISTOL MYERS SQUIBB CO | 2011-03-09 | — | — | CN | disclosed |
| WO-2011024691-A1 | PROCESS FOR PREPARATION OF OPTICALLY ACTIVE ETHYL 1-AMINO-2-ETHENYLCYCLOPROPANECARBOXYLATE | 住友化学株式会社 (JP) | 2011-03-03 | — | — | WO | disclosed |
| EP-1673385-B1 | MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS | BOEHRINGER INGELHEIM INT (DE) | 2011-03-02 | — | — | EP | disclosed |
| WO-2011014487-A1 | HEPATITIS C VIRUS NS3 PROTEASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2011-02-03 | — | — | WO | disclosed |
| EP-1919899-B1 | MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS | TIBOTEC PHARM LTD (IE) | 2011-01-19 | — | — | EP | disclosed |
| EP-1730167-B1 | MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS | BOEHRINGER INGELHEIM INT (DE) | 2011-01-12 | — | — | EP | disclosed |
| WO-2011003063-A2 | ENZYMES AND METHODS FOR RESOLVING AMINO VINYL CYCLOPROPANE CARBOXYLIC ACID DERIVATIVES | DR. REDDY'S LABORATORIES LTD. (IN) | 2011-01-06 | — | — | WO | disclosed |
| CN-101143892-B | Method for resolving enantiomer by enzyme catalysis | BOEHRINGER INGELHEIM CA LTD | 2010-12-08 | — | — | CN | disclosed |
| US-7829665-B2 | Macrocyclic inhibitors of hepatitis C virus replication | INTERMUNE, INC. (US) | 2010-11-09 | — | — | US | disclosed |
| EP-1599496-B1 | HEPATITIS C INHIBITOR PEPTIDE ANALOGS | BOEHRINGER INGELHEIM INT (DE) | 2010-11-03 | — | — | EP | disclosed |
| US-20100272674-A1 | Hepatitis C Virus Inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2010-10-28 | — | — | US | disclosed |
| US-RE41894-E1 | Hepatitis C inhibitor tri-peptides | BOEHRINGER INGELHEIM CANADA LTD. (CA) | 2010-10-26 | — | — | US | disclosed |
| WO-2010118078-A1 | MACROCYCLIC SERINE PROTEASE INHIBITORS | IDENIX PHARMACEUTICALS, INC. (US) | 2010-10-14 | — | — | WO | disclosed |
| CN-101784549-A | Novel macrocyclic inhibitors of hepatitis c virus replication | INTERMUNE INC | 2010-07-21 | — | — | CN | disclosed |
| US-7749961-B2 | Macrocyclic peptides active against the hepatitis C virus | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-07-06 | — | — | US | disclosed |
| WO-2010065577-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-06-10 | — | — | WO | disclosed |
| US-7728148-B2 | Acyclic oximyl hepatitis C protease inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2010-06-01 | — | — | US | disclosed |
| US-RE41356-E1 | Hepatitis C inhibitor tri-peptides | BOEHRINGER INGELHEIM CANADA LTD. (CA) | 2010-05-25 | — | — | US | disclosed |
| US-7696242-B2 | Hepatitis C inhibitor peptide analogs | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-04-13 | — | — | US | disclosed |
| EP-2160392-A2 | NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION | Intermune, Inc. (US) | 2010-03-10 | — | — | EP | disclosed |
| US-20100028300-A1 | MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-02-04 | — | — | US | disclosed |
| US-7642235-B2 | Macrocyclic peptides active against the hepatitis C virus | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-01-05 | — | — | US | disclosed |
| WO-2009148923-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-12-10 | — | — | WO | disclosed |
| US-20090297472-A1 | Hepatitis C Virus Inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2009-12-03 | — | — | US | disclosed |
| US-20090292129-A1 | PROCESS FOR RESOLVING RACEMIC MIXTURES AND A DIASTEREOISOMERIC COMPLEX OF A RESOLVING AGENT AND AN ENANTIOMER OF INTEREST | ABIOGEN PHARMA S.P.A. (IT) | 2009-11-26 | — | — | US | disclosed |
| CN-101568346-A | Hcv ns3 protease inhibitors | MERCK & CO INC (US) | 2009-10-28 | — | — | CN | disclosed |
| US-20090264346-A1 | MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-10-22 | — | — | US | disclosed |
| EP-1558632-B1 | MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS | BOEHRINGER INGELHEIM INT (DE) | 2009-09-23 | — | — | EP | disclosed |
| EP-2103623-A2 | Novel macrocyclic inhibitors of Hepatitis C virus replication | Intermune, Inc. (US) | 2009-09-23 | — | — | EP | disclosed |
| CN-101541784-A | Hepatitis C virus inhibitors | BRISTOL MYERS SQUIBB CO (US) | 2009-09-23 | — | — | CN | disclosed |
| US-7585845-B2 | Hepatitis C inhibitor compounds | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-09-08 | — | — | US | disclosed |
| EP-2086982-A1 | HCV NS3 PROTEASE INHIBITORS | Merck & Co., Inc. (US) | 2009-08-12 | — | — | EP | disclosed |
| US-20090169510-A1 | NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION | INTERMUNE, INC. (US) | 2009-07-02 | — | — | US | disclosed |
| US-20090148407-A1 | Novel Macrocyclic Inhibitors of Hepatitis C Virus Replication | INTERMUNE, INC. (US) | 2009-06-11 | — | — | US | disclosed |
| EP-1771454-A4 | HEPATITIS C INHIBITOR PEPTIDE ANALOGS | BOEHRINGER INGELHEIM INT (DE) | 2009-05-13 | — | — | EP | disclosed |
| EP-1105413-B1 | HEPATITIS C INHIBITOR TRI-PEPTIDES | BOEHRINGER INGELHEIM CA LTD (CA) | 2009-04-29 | — | — | EP | disclosed |
| US-7504378-B2 | Macrocyclic peptides active against the hepatitis C virus | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-03-17 | — | — | US | disclosed |
| CN-101379029-A | A process for resolving racemic mixtures and a diastereoisomeric complex of a resolving agent and an enantiomer of interest | ABIOGEN PHARMA SPA (IT) | 2009-03-04 | — | — | CN | disclosed |
| EP-2028186-A2 | Hepatitis C inhibitor tri-peptides | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2009-02-25 | — | — | EP | disclosed |
| EP-2028186-A2 | Hepatitis C inhibitor tri-peptides | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2009-02-25 | — | — | EP | disclosed |
| US-20090047244-A1 | MACROCYCLIC SERINE PROTEASE INHIBITORS I | IDENIX PHARMACEUTICALS, INC. (US) | 2009-02-19 | — | — | US | disclosed |
| WO-2009014730-A1 | MACROCYCLIC SERINE PROTEASE INHIBITORS | IDENIX PHARMACEUTICALS, INC. (US) | 2009-01-29 | — | — | WO | disclosed |
| US-20080292587-A1 | OXIMYL DIPEPTIDE HEPATITIS C PROTEASE INHIBITORS | ENANTA PHARMACEUTICALS, INC. | 2008-11-27 | — | — | US | disclosed |
| US-20080286233-A1 | PIPERIZINYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS | ENANTA PHARMACEUTICALS, INC. | 2008-11-20 | — | — | US | disclosed |
| WO-2008137779-A2 | NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION | INTERMUNE, INC. (US) | 2008-11-13 | — | — | WO | disclosed |
| EP-1472278-B1 | MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS | BOEHRINGER INGELHEIM CA LTD (CA) | 2008-11-12 | — | — | EP | disclosed |
| WO-2008134398-A1 | OXIMYL DIPEPTIDE HEPATITIS C PROTEASE INHIBITORS | ENANTA PHARMACEUTICALS, INC. (US) | 2008-11-06 | — | — | WO | disclosed |
| EP-1986996-A2 | A PROCESS FOR RESOLVING RACEMIC MIXTURES AND A DIASTEREOISOMERIC COMPLEX OF A RESOLVING AGENT AND AN ENANTIOMER OF INTEREST | Abiogen Pharma S.p.A. (IT) | 2008-11-05 | — | — | EP | disclosed |
| CN-100430414-C | Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of NS3 (hepatitis C) | BOEHRINGER INGELHEIM INT (DE) | 2008-11-05 | — | — | CN | disclosed |
| US-RE40525-E1 | Hepatitis C inhibitor tri-peptides | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2008-09-30 | — | — | US | disclosed |
| CN-101273038-A | Macrocylic inhibitors of hepatitis C virus | MEDIVIR AB (SE) | 2008-09-24 | — | — | CN | disclosed |
| US-20080187516-A1 | ACYCLIC OXIMYL HEPATITIS C PROTEASE INHIBITORS | ENANTA PHARMACEUTICALS, INC. | 2008-08-07 | — | — | US | disclosed |
| CN-101228180-A | Tripeptides as hepatitis C virus inhibitors | BRISTOL MYERS SQUIBB CO (US) | 2008-07-23 | — | — | CN | disclosed |
| CN-100391967-C | Hepatitis C tripeptide inhibitors | BRISTOL MYERS SQUIBB CO (US) | 2008-06-04 | — | — | CN | disclosed |
| US-20080125444-A1 | ACYCLIC OXIMYL HEPATITIS C PROTEASE INHIBITORS | ENANTA PHARMACEUTICALS, INC. | 2008-05-29 | — | — | US | disclosed |
| WO-2008057209-A1 | HCV NS3 PROTEASE INHIBITORS | MERCK & CO., INC. (US) | 2008-05-15 | — | — | WO | disclosed |
| EP-1730167-A4 | MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS | BOEHRINGER INGELHEIM INT (DE) | 2008-04-09 | — | — | EP | disclosed |
| CN-101143892-A | Hepatitis c inhibitor tri-peptides | BOEHRINGER INGELHEIM CA LTD (CA) | 2008-03-19 | — | — | CN | disclosed |
| EP-1879607-A2 | HCV NS3 PROTEASE INHIBITORS | Merck & Co., Inc. (US) | 2008-01-23 | — | — | EP | disclosed |
| WO-2007146695-A1 | ACYCLIC OXIMYL HEPATITIS C PROTEASE INHIBITORS | ENANTA PHARMACEUTICALS, INC. (US) | 2007-12-21 | — | — | WO | disclosed |
| EP-1654261-B1 | HEPATITIS C INHIBITOR COMPOUNDS | BOEHRINGER INGELHEIM INT (DE) | 2007-11-14 | — | — | EP | disclosed |
| WO-2007088571-A2 | A PROCESS FOR RESOLVING RACEMIC MIXTURES AND A DIASTEREOISOMERIC COMPLEX OF A RESOLVING AGENT AND AN ENANTIOMER OF INTEREST | ABIOGEN PHARMA S.P.A. (IT) | 2007-08-09 | — | — | WO | disclosed |
| EP-1474423-B1 | HETEROCYCLIC TRIPEPTIDES AS HEPATITIS C INHIBITORS | BOEHRINGER INGELHEIM INT (DE) | 2007-08-08 | — | — | EP | disclosed |
| EP-1771454-A1 | HEPATITIS C INHIBITOR PEPTIDE ANALOGS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-04-11 | — | — | EP | disclosed |
| EP-1474441-B1 | TRIPEPTIDES HAVING A HYDROXYPROLINE ETHER OF A SUBSTITUTED QUINOLINE FOR THE INHIBITION OF NS3 (HEPATITIS C) | BOEHRINGER INGELHEIM INT (DE) | 2007-03-28 | — | — | EP | disclosed |
| CN-1304416-C | Heterocyclic tripeptides as hepatitis C inhibitors | BOEHRINGER INGELHEIM INT (DE) | 2007-03-14 | — | — | CN | disclosed |
| WO-2007015824-A2 | NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION | INTERMUNE, INC. (US) | 2007-02-08 | — | — | WO | disclosed |
| EP-1730167-A1 | MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS | Boehringer Ingelheim International GmbH (DE) | 2006-12-13 | — | — | EP | disclosed |
| WO-2006119061-A2 | HCV NS3 PROTEASE INHIBITORS | MERCK & CO., INC. (US) | 2006-11-09 | — | — | WO | disclosed |
| CN-1856502-A | Macrocyclic peptides active against hepatitis C virus | BOEHRINGER INGELHEIM INT (DE) | 2006-11-01 | — | — | CN | disclosed |
| US-7119072-B2 | Inhibitors of the HCV NS3 protease. | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2006-10-10 | — | — | US | disclosed |
| EP-1673385-A4 | MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS | BOEHRINGER INGELHEIM INT (DE) | 2006-10-04 | — | — | EP | disclosed |
| US-7091184-B2 | Hepatitis C inhibitor tri-peptides | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2006-08-15 | — | — | US | disclosed |
| EP-1680137-A2 | MACROCYCLIC CARBOXYLIC ACIDS AND ACYLSULFONAMIDES AS INHIBITORS OF HCV REPLICATION | Intermune, Inc. (US) | 2006-07-19 | — | — | EP | disclosed |
| EP-1673385-A1 | MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS | Boehringer Ingelheim International GmbH (DE) | 2006-06-28 | — | — | EP | disclosed |
| CN-1791599-A | Hepatitis c inhibitor compounds | BOEHRINGER INGELHEIM INT (DE) | 2006-06-21 | — | — | CN | disclosed |
| EP-1337550-B1 | HEPATITIS C TRIPEPTIDE INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2006-05-24 | — | — | EP | disclosed |
| EP-1654261-A1 | HEPATITIS C INHIBITOR COMPOUNDS | Boehringer Ingelheim International GmbH (DE) | 2006-05-10 | — | — | EP | disclosed |
| US-20060089300-A1 | Macrocyclic peptides active against the hepatitis C virus | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2006-04-27 | — | — | US | disclosed |
| EP-1105422-B1 | HEPATITIS C INHIBITOR PEPTIDES | BOEHRINGER INGELHEIM CA LTD (CA) | 2006-02-15 | — | — | EP | disclosed |
| US-20060019905-A1 | inhibitors of the hepatitis C virus NS3 protease; azalactone intermediate reacted with cycloalkylsulfonamide and decylization; urea or carbamate-terminated alkylglycine, hydroxyproline, cyclopropylglycine tripeptide | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2006-01-26 | — | — | US | disclosed |
| WO-2006007708-A1 | HEPATITIS C INHIBITOR PEPTIDE ANALOGS | BOEHRINGER ENGELHEIM INTERNATIONAL GMBH (DE) | 2006-01-26 | — | — | WO | disclosed |
| EP-1601685-A1 | HEPATITIS C INHIBITING COMPOUNDS | Boehringer Ingelheim International GmbH (DE) | 2005-12-07 | — | — | EP | disclosed |
| EP-1599496-A2 | HEPATITIS C INHIBITOR PEPTIDE ANALOGS | Boehringer Ingelheim International GmbH (DE) | 2005-11-30 | — | — | EP | disclosed |
| US-20050192212-A1 | Macrocyclic peptides active against the hepatitis C virus | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-09-01 | — | — | US | disclosed |
| WO-2005070955-A1 | MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-08-04 | — | — | WO | disclosed |
| EP-1558632-A1 | MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS | Boehringer Ingelheim International GmbH (DE) | 2005-08-03 | — | — | EP | disclosed |
| CN-1642974-A | Tripeptides with hydroxyproline ethers of substituted quinolines for the inhibition of NS3 (hepatitis C) | BOEHRINGER INGELHEIM INT (DE) | 2005-07-20 | — | — | CN | disclosed |
| CN-1642951-A | Heterocyclic tripeptides as hepatitis c inhibitors | BOEHRINGER INGELHEIM INT (DE) | 2005-07-20 | — | — | CN | disclosed |
| US-6919423-B2 | Hepatitis C inhibitor compound | BOEHRINGER INGELHEIM INTERNATIONAL, GMBH (DE) | 2005-07-19 | — | — | US | disclosed |
| CN-1639187-A | Macrocyclic peptides active against the hepatitis C virus | BOEHRINGER INGELHEIM CA LTD (CA) | 2005-07-13 | — | — | CN | disclosed |
| US-6908901-B2 | Hepatitis C inhibitor peptide analogs | BOEHRINGER INGELHEIM INTERNATIONAL, GMBH (DE) | 2005-06-21 | — | — | US | disclosed |
| WO-2005054430-A2 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-06-16 | — | — | WO | disclosed |
| WO-2005037214-A2 | MACROCYCLIC CARBOXYLIC ACIDS AND ACYLSULFONAMIDES AS INHIBITORS OF HCV REPLICATION | INTERMUNE, INC. (US) | 2005-04-28 | — | — | WO | disclosed |
| US-20050080005-A1 | Macrocyclic peptides active against the hepatitis C virus | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-04-14 | — | — | US | disclosed |
| US-20050075279-A1 | Macrocyclic peptides active against the hepatitis C virus | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-04-07 | — | — | US | disclosed |
| WO-2005028501-A1 | MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-03-31 | — | — | WO | disclosed |
| US-6872805-B2 | Hepatitis C virus inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-03-29 | — | — | US | disclosed |
| US-20050020503-A1 | Hepatitis C inhibitor compounds | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-01-27 | — | — | US | disclosed |
| WO-2004103996-A1 | HEPATITIS C INHIBITOR COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2004-12-02 | — | — | WO | disclosed |
| WO-2004101605-A1 | HEPATITIS C INHIBITING COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2004-11-25 | — | — | WO | disclosed |
| WO-2004101602-A2 | HEPATITIS C INHIBITOR PEPTIDE ANALOGS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2004-11-25 | — | — | WO | disclosed |
| US-20040229818-A1 | Hepatitis C inhibitor compound | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2004-11-18 | — | — | US | disclosed |
| US-20040224900-A1 | Hepatitis C inhibitor peptide analogs | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2004-11-11 | — | — | US | disclosed |
| EP-1474441-A1 | TRIPEPTIDES HAVING A HYDROXYPROLINE ETHER OF A SUBSTITUTED QUINOLINE FOR THE INHIBITION OF NS3 (HEPATITIS C) | Boehringer Ingelheim International GmbH (DE) | 2004-11-10 | — | — | EP | disclosed |
| EP-1474423-A1 | HETEROCYCLIC TRIPEPTIDES AS HEPATITIS C INHIBITORS | Boehringer Ingelheim International GmbH (DE) | 2004-11-10 | — | — | EP | disclosed |
| EP-1472278-A2 | MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2004-11-03 | — | — | EP | disclosed |
| CN-1531547-A | Hepatitis C tripeptide inhibitors | ж� | 2004-09-22 | — | — | CN | disclosed |
| CN-1166690-C | Hepatitis C inhibitor peptides | ���ָ����Ӣ��ķ���ô�����˾ | 2004-09-15 | — | — | CN | disclosed |
| US-6767991-B1 | PEPTIDES AND ANALOGS THEREOF; VIRAL PROTEASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH PEPTIDES AND RIBAVIRIN | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2004-07-27 | — | — | US | disclosed |
| WO-2004037855-A1 | MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2004-05-06 | — | — | WO | disclosed |
| US-20030224977-A1 | Macrocyclic peptides active against the hepatitis C virus | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2003-12-04 | — | — | US | disclosed |
| US-20030191067-A1 | Hepatitis C inhibitor tri-peptides | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2003-10-09 | — | — | US | disclosed |
| US-20030186895-A1 | Hepatitis C inhibitor tri-peptides | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2003-10-02 | — | — | US | disclosed |
| US-20030187018-A1 | Hepatitis C inhibitor tri-peptides | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2003-10-02 | — | — | US | disclosed |
| US-20030181363-A1 | Macrocyclic peptides active against the hepatitis C virus | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2003-09-25 | — | — | US | disclosed |
| EP-1337550-A2 | HEPATITIS C TRIPEPTIDE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-08-27 | — | — | EP | disclosed |
| WO-2003064455-A2 | MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2003-08-07 | — | — | WO | disclosed |
| WO-2003064456-A1 | TRIPEPTIDES HAVING A HYDROXYPROLINE ETHER OF A SUBSTITUTED QUINOLINE FOR THE INHIBITION OF NS3 (HEPATITIS C) | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2003-08-07 | — | — | WO | disclosed |
| WO-2003064416-A1 | HETEROCYCLIC TRIPEPTIDES AS HEPATITIS C INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2003-08-07 | — | — | WO | disclosed |
| US-20020111313-A1 | Hepatitis C virus inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2002-08-15 | — | — | US | disclosed |
| WO-2002060926-A2 | HEPATITIS C TRIPEPTIDE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-08-08 | — | — | WO | disclosed |
| US-6420380-B2 | FOR TREATMENT OF HEPATITIS C VIRUS (HCV) INFECTION | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2002-07-16 | — | — | US | disclosed |
| US-6410531-B1 | FOR THERAPY OF HEPATITIS C VIRUS (HCV) INFECTION | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2002-06-25 | — | — | US | disclosed |
| US-20020037998-A1 | Hepatitis C inhibitor tri-peptides | LLINAS-BRUNET MONTSE (CA) | 2002-03-28 | — | — | US | disclosed |
| US-20020016442-A1 | Hepatitis C inhibitor tri-peptides | LLINAS-BRUNET MONTSE (CA) | 2002-02-07 | — | — | US | disclosed |
| US-6329379-B1 | OLIGOPEPTIDES FOR INHIBITING HEPATITIS | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2001-12-11 | — | — | US | disclosed |
| US-6329417-B1 | RACEMATES, DIASTEREOISOMERS AND OPTICAL ISOMERS; PROTEASE INHIBITOR PEPTIDE ANALOG | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2001-12-11 | — | — | US | disclosed |
| US-6323180-B1 | PROTEASE INHIBITORS; INHIBIT REPLICATION OF HEPATITIS C VIRUS | BOEHRINGER INGELHEIM (CANADA) LTD (CA) | 2001-11-27 | — | — | US | disclosed |
| CN-1323316-A | Hepatitis C tripeptide inhibitors | BOEHRINGER INGELHEIM CA LTD (CA) | 2001-11-21 | — | — | CN | disclosed |
| CN-1315965-A | Hepatitis C inhibitor peptides | BOEHRINGER INGELHEIM CA LTD (CA) | 2001-10-03 | — | — | CN | disclosed |
| US-6268207-B1 | RESOLUTION OF ENANTIOMERS FROM A MIXTURE OF (1R,2S)/(1S,2S)-1-AMINO-2-VINYLCYCLOPROPYL CARBOXYLIC ACID METHYL ESTER COMPRISING THE STEP OF TREATING SAID MIXTURE WITH AN ESTERASE TO OBTAIN THE CORRESPONDING (1R,2S) ENANTIOMER | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2001-07-31 | — | — | US | disclosed |
| EP-1105422-A1 | HEPATITIS C INHIBITOR PEPTIDES | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2001-06-13 | — | — | EP | disclosed |
| EP-1105413-A2 | HEPATITIS C INHIBITOR TRI-PEPTIDES | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2001-06-13 | — | — | EP | disclosed |
| WO-2000009558-A1 | HEPATITIS C INHIBITOR PEPTIDES | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2000-02-24 | — | — | WO | disclosed |
| WO-2000009558-A1 | HEPATITIS C INHIBITOR PEPTIDES | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2000-02-24 | — | — | WO | disclosed |
| WO-2000009543-A2 | HEPATITIS C INHIBITOR TRI-PEPTIDES | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2000-02-24 | — | — | WO | disclosed |